Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 23 Jul 2026 | 2,065,672 | 0 | - | - | Series B Preferred Stock | ||
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 23 Jul 2026 | 1,000,000 | 1,348,825 | - | 15 | 15,000,000 | Common Stock |
| Neuronetics Inc | Mr. Nir Naor | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 500,000 | 500,000 (2%) | 2% | 0 | Common Stock | |
| Immunome Inc | Dr. Clay B. Siegall,PhD | Director, President and CEO | 23 Jul 2026 | 360,000 | 360,000 | - | - | Employee Stock Option (right to buy) | ||
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 23 Jul 2026 | 348,825 | 348,825 | - | - | Common Stock | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.34 per share. | 23 Jul 2026 | 256,918 | 244,730 (0%) | 0% | 24.3 | 6,253,384 | Class A Common Stock |
| Standard BioTools Inc | Mr. Hanjoon Alex Kim | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 23 Jul 2026 | 202,476 | 2,563,054 (3%) | 0% | 0.9 | 181,216 | Common Stock |
| Immunome Inc | Dr. Clay B. Siegall,PhD | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 180,000 | 870,704 | - | 0 | Common Stock | |
| AAR Corp | Mr. John M. Holmes | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 161,500 | 481,725 (1%) | 0% | 0 | Common Stock | |
| Nexgel Inc | Mr. Adam Levy | Director, Chief Executive Officer | 23 Jul 2026 | 160,000 | 160,000 | - | - | Stock Option (Right to Buy) | ||
| Caring Brands | Mr. Brian S. John | Director, Interim CFO | Other type of transaction at price $ 1.00 per share. | 23 Jul 2026 | 150,000 | 600,000 | - | 1 | 150,000 | Common Stock |
| Celsius Holdings Inc | Mr. William H. Milmoe | Former 10% owner | 23 Jul 2026 | 150,000 | 11,932,396 (17%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Mr. William H. Milmoe | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Mr. William H. Milmoe | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Mr. William H. Milmoe | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Mr. William H. Milmoe | Former 10% owner | 23 Jul 2026 | 150,000 | 11,632,396 (16%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Mr. William H. Milmoe | Former 10% owner | 23 Jul 2026 | 150,000 | 11,782,396 (17%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Mr. Dean Desantis | Former 10% owner | 23 Jul 2026 | 150,000 | 11,932,396 (17%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Mr. Dean Desantis | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Mr. Dean Desantis | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Mr. Dean Desantis | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Mr. Dean Desantis | Former 10% owner | 23 Jul 2026 | 150,000 | 11,632,396 (16%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Mr. Dean Desantis | Former 10% owner | 23 Jul 2026 | 150,000 | 11,782,396 (17%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Ms. Deborah DeSantis | Former 10% owner | 23 Jul 2026 | 150,000 | 11,782,396 (17%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Ms. Deborah DeSantis | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Ms. Deborah DeSantis | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Ms. Deborah DeSantis | Former 10% owner | 23 Jul 2026 | 150,000 | 0 | - | - | Variable Prepaid Forward Sale Contract (obligation to sell) | ||
| Celsius Holdings Inc | Ms. Deborah DeSantis | Former 10% owner | 23 Jul 2026 | 150,000 | 11,632,396 (16%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Celsius Holdings Inc | Ms. Deborah DeSantis | Former 10% owner | 23 Jul 2026 | 150,000 | 11,932,396 (17%) | 0% | 46.3 | 6,937,905 | Common Stock | |
| Loop Ind Inc | Mr. Laurence G. Sellyn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 140,350 | 587,711 (1%) | 0% | 0 | Common Stock | |
| Rent the Runway Inc (Class A) | Mr. Dhiren R. Fonseca | Director | 23 Jul 2026 | 134,648 | 134,648 | - | 0 | Class A Common Stock | ||
| Rent the Runway Inc (Class A) | Mr. Dhiren R. Fonseca | Director | 23 Jul 2026 | 134,648 | 134,648 | - | - | Restricted Stock Units | ||
| Immunome Inc | Mr. Robert Lechleider | Chief Medical Officer | 23 Jul 2026 | 108,000 | 108,000 | - | - | Employee Stock Option (right to buy) | ||
| Loop Ind Inc | Ms. Louise S. Sams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 105,263 | 259,678 (0%) | 0% | 0 | Common Stock | |
| Loop Ind Inc | Mr. Laurent Auguste | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 105,263 | 203,486 (0%) | 0% | 0 | Common Stock | |
| Loop Ind Inc | Mr. Jay Stubina | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 105,263 | 308,178 (0%) | 0% | 0 | Common Stock | |
| Loop Ind Inc | Mr. Jeffrey R. Geygan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 105,263 | 203,963 (0%) | 0% | 0 | Common stock, par value $0.0001 per share | |
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Sale of securities on an exchange or to another person at price $ 24.22 per share. | 23 Jul 2026 | 98,144 | 98,747 (0%) | 0% | 24.2 | 2,377,048 | Class A Common Stock |
| Brown Forman | Mr. Lawson E. Whiting | Director, President & CEO | 23 Jul 2026 | 95,484 | 95,484 | - | - | Restricted Stock Units | ||
| Immunome Inc | Mr. Max Rosett | Chief Financial Officer | 23 Jul 2026 | 94,500 | 94,500 | - | - | Employee Stock Option (right to buy) | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 89,440 | 89,440 | - | - | Class B Common Stock | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 89,440 | 0 | - | - | Stock Appreciation Rights | ||
| Yarrow Bioscience Inc | David Domzalski | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 23 Jul 2026 | 79,391 | 347,174 (1%) | 0% | 0.9 | 71,261 | Common Stock |
| Immunome Inc | Ms. Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | 23 Jul 2026 | 76,500 | 76,500 | - | - | Employee Stock Option (right to buy) | ||
| Immunome Inc | Dr. Jack Higgins, PhD | Chief Scientific Officer | 23 Jul 2026 | 76,500 | 76,500 | - | - | Employee Stock Option (right to buy) | ||
| Immunome Inc | Mr. Philip Tsai, PhD | Chief Technical Officer | 23 Jul 2026 | 76,500 | 76,500 | - | - | Employee Stock Option (right to buy) | ||
| Planet Labs PBC (Class A) | Ms. Ashley Fieglein Johnson | President & CFO | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 23 Jul 2026 | 75,035 | 1,132,122 | - | 22.1 | 1,656,803 | Class A Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 73,616 | 0 | - | - | Stock Appreciation Rights | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.00 per share. | 23 Jul 2026 | 73,616 | 356,184 (0%) | 0% | 21 | 1,545,936 | Class A Common Stock |
| Nauticus Robotics Inc | Mr. William H. Flores, C.P.A. | Director | 23 Jul 2026 | 72,361 | 72,361 | - | - | Restricted Stock Unit | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 72,015 | 17,425 | - | - | Class B Common Stock | ||
| Planet Labs PBC (Class A) | Ms. Ashley Fieglein Johnson | President & CFO | Other type of transaction at price $ 0.00 per share. | 23 Jul 2026 | 70,767 | 1,207,157 | - | 0 | Class A Common Stock | |
| Planet Labs PBC (Class A) | Ms. Ashley Fieglein Johnson | President & CFO | Other type of transaction at price $ 0.00 per share. | 23 Jul 2026 | 70,767 | 596,475 | - | 0 | Class A Common Stock | |
| Hexcel Corp | Mr. Nick L. Stanage | Director | 23 Jul 2026 | 70,293 | 0 | - | - | Non-Qualified Stock Options | ||
| Hexcel Corp | Mr. Nick L. Stanage | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.74 per share. | 23 Jul 2026 | 70,293 | 566,537 (0%) | 0% | 74.7 | 5,253,699 | Common Stock |
| Intuit | Mr. Sasan K. Goodarzi | Director, Chairman and CEO | 23 Jul 2026 | 69,434 | 69,434 | - | - | Non-Qualified Stock Options (right to buy) | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 66,207 | 0 | - | - | Stock Appreciation Rights | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.79 per share. | 23 Jul 2026 | 66,207 | 422,391 (0%) | 0% | 17.8 | 1,177,823 | Class A Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 65,789 | 0 | - | - | Stock Appreciation Rights | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.25 per share. | 23 Jul 2026 | 65,789 | 231,961 (0%) | 0% | 20.2 | 1,332,227 | Class A Common Stock |
| Brown Forman | Mr. James W. Peters | EVP, Chief Financial Officer | 23 Jul 2026 | 64,933 | 64,933 | - | - | Restricted Stock Units | ||
| Immunome Inc | Mr. Kinney Horn | CHIEF BUSINESS OFFICER | 23 Jul 2026 | 62,500 | 62,500 | - | - | Employee Stock Option (right to buy) | ||
| Bentley Systems Inc (Class B) | Mr. Gregory S. Bentley | Director, Executive Chair & President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 30.12 per share. | 23 Jul 2026 | 61,037 | 7,717,545 | - | 30.1 | 1,838,434 | Class B Common Stock |
| Symbotic Inc (Class A) | Ms. Izilda P. Martins | Chief Financial Officer | 23 Jul 2026 | 59,134 | 118,287 | - | - | Restricted Stock Units | ||
| Symbotic Inc (Class A) | Ms. Izilda P. Martins | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 59,134 | 62,634 | - | - | Class A Common Stock | |
| Hexcel Corp | Mr. Nick L. Stanage | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.70 per share. | 23 Jul 2026 | 57,174 | 509,363 (0%) | 0% | 110.7 | 6,329,162 | Common Stock |
| Immunome Inc | Mr. Robert Lechleider | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 54,000 | 69,805 | - | 0 | Common Stock | |
| Intuit | Mr. Sasan K. Goodarzi | Director, Chairman and CEO | 23 Jul 2026 | 52,064 | 52,064 | - | - | Restricted Stock Units (performance-based vesting) | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 50,607 | 0 | - | - | Stock Appreciation Rights | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.35 per share. | 23 Jul 2026 | 50,607 | 282,568 (0%) | 0% | 21.3 | 1,080,459 | Class A Common Stock |
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.35 per share. | 23 Jul 2026 | 49,979 | 31,692 | - | 12.3 | 617,006 | Class A Common Stock |
| Nauticus Robotics Inc | Mr. Elliot Spiro | Director | 23 Jul 2026 | 48,241 | 48,241 | - | - | Restricted Stock Unit | ||
| Nauticus Robotics Inc | Mr. Jim Bellingham | Director | 23 Jul 2026 | 48,241 | 48,241 | - | - | Restricted Stock Unit | ||
| Nauticus Robotics Inc | Mr. Adam Sharkawy | Director | 23 Jul 2026 | 48,241 | 48,241 | - | - | Restricted Stock Unit | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. | 23 Jul 2026 | 47,839 | 196,891 (0%) | 0% | 24.3 | 1,161,531 | Class A Common Stock |
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 47,710 | 0 | - | - | Stock Appreciation Rights | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.58 per share. | 23 Jul 2026 | 47,710 | 470,101 (0%) | 0% | 16.6 | 791,032 | Class A Common Stock |
| Immunome Inc | Mr. Max Rosett | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 47,250 | 101,287 | - | 0 | Common Stock | |
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | 23 Jul 2026 | 47,054 | 8,846,551 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | 23 Jul 2026 | 47,054 | 659,801 (1%) | 0% | 0 | Class A Common Stock | ||
| Immunome Inc | Ms. Sandra G. Stoneman | CHIEF LEGAL OFFICER & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 38,250 | 43,805 | - | 0 | Common Stock | |
| Immunome Inc | Dr. Jack Higgins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 38,250 | 60,250 | - | 0 | Common Stock | |
| Immunome Inc | Mr. Philip Tsai, PhD | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 38,250 | 81,550 | - | 0 | Common Stock | |
| Planet Labs PBC (Class A) | Ms. Ashley Fieglein Johnson | President & CFO | Sale of securities on an exchange or to another person at price $ 22.08 per share. | 23 Jul 2026 | 34,993 | 561,482 | - | 22.1 | 772,659 | Class A Common Stock |
| Rent the Runway Inc (Class A) | Mr. Dhiren R. Fonseca | Director | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 23 Jul 2026 | 34,516 | 100,132 | - | 3.0 | 103,220 | Class A Common Stock |
| Travel+Leisure Co | Ms. Kimberly Marshall | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 23 Jul 2026 | 32,691 | 0 (0%) | 0% | 75 | 2,451,825 | Common Stock |
| Intuit | Mr. Sandeep S. Aujla | EVP and CFO | 23 Jul 2026 | 32,606 | 32,606 | - | - | Restricted Stock Units | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 31,547 | 0 | - | - | Stock Appreciation Rights | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.03 per share. | 23 Jul 2026 | 31,547 | 501,648 (0%) | 0% | 19.0 | 600,339 | Class A Common Stock |
| Intuit | Mr. Sasan K. Goodarzi | Director, Chairman and CEO | 23 Jul 2026 | 31,338 | 31,338 | - | - | Restricted Stock Units | ||
| Immunome Inc | Mr. Kinney Horn | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 31,250 | 31,250 | - | 0 | Common Stock | |
| AAR Corp | Mr. John M. Holmes | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 30,123 | 320,225 (0%) | 0% | 0 | Common Stock | |
| Symbotic Inc (Class A) | Ms. Izilda P. Martins | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.80 per share. | 23 Jul 2026 | 27,463 | 35,171 | - | 40.8 | 1,120,490 | Class A Common Stock |
| Intuit | Mr. Sandeep S. Aujla | EVP and CFO | 23 Jul 2026 | 27,086 | 27,086 | - | - | Restricted Stock Units (performance-based vesting) | ||
| Bentley Systems Inc (Class B) | Mr. Gregory S. Bentley | Director, Executive Chair & President, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.12 per share. | 23 Jul 2026 | 26,698 | 7,690,847 | - | 30.1 | 804,144 | Class B Common Stock |
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 244.47 per share. | 23 Jul 2026 | 25,234 | 625,035 (0%) | 0% | 244.5 | 6,169,027 | Class A Common Stock |
| U.S. Bancorp | Mr. James L. Chosy | Senior EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.01 per share. | 23 Jul 2026 | 24,711 | 275,652 (0%) | 0% | 55.0 | 1,359,352 | Common Stock, $0.01 par value |
| U.S. Bancorp | Mr. James L. Chosy | Senior EVP and General Counsel | 23 Jul 2026 | 24,711 | 0 | - | - | Employee Stock Option (Right to Buy) | ||
| U.S. Bancorp | Mr. James L. Chosy | Senior EVP and General Counsel | Sale of securities on an exchange or to another person at price $ 63.28 per share. | 23 Jul 2026 | 22,968 | 252,684 (0%) | 0% | 63.3 | 1,453,415 | Common Stock, $0.01 par value |
| Yarrow Bioscience Inc | Mutya Harsch | CHIEF LEGAL OFFICER AND GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 23 Jul 2026 | 22,516 | 95,918 (0%) | 0% | 0.9 | 20,210 | Common Stock |
| Yarrow Bioscience Inc | Tyler Zeronda | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 23 Jul 2026 | 22,516 | 74,918 (0%) | 0% | 0.9 | 20,210 | Common Stock |
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 23 Jul 2026 | 21,870 | 69,171 | - | - | Class A Common Stock | ||
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 23 Jul 2026 | 21,870 | 116,829 | - | - | Stock Option (Right to buy Class B Common Stock) | ||
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 23 Jul 2026 | 21,870 | 232,854 | - | - | Class B Common Stock | ||
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 23 Jul 2026 | 21,870 | 210,984 | - | - | Class B Common Stock | ||
| Symbotic Inc (Class A) | Mr. Brian Daniel Alexander | SVP, Commercial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 20,512 | 64,741 | - | - | Class A Common Stock | |
| Symbotic Inc (Class A) | Mr. Brian Daniel Alexander | SVP, Commercial | 23 Jul 2026 | 20,512 | 143,587 | - | - | Restricted Stock Units | ||
| AAR Corp | Mr. John M. Holmes | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 20,082 | 290,102 (0%) | 0% | 0 | Common Stock | |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | 23 Jul 2026 | 20,000 | 21,640 (0%) | 0% | 0 | Class A Common Stock | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | 23 Jul 2026 | 20,000 | 250,059 | - | - | Class B Common Stock | ||
| Deep Fission Inc | Mr. Leslie Goldman Tepper | Director | 23 Jul 2026 | 19,204 | 19,204 | - | - | Restricted Stock Unit | ||
| Deep Fission Inc | Mr. Thomas S. Glanville | Director | 23 Jul 2026 | 19,156 | 19,156 | - | - | Restricted Stock Unit | ||
| Deep Fission Inc | Mr. Blake E. Janover | Director | 23 Jul 2026 | 18,962 | 18,962 | - | - | Restricted Stock Unit | ||
| Intuit | Ms. Lauren D. Hotz | SVP, Chief Accounting Officer | 23 Jul 2026 | 18,114 | 18,114 | - | - | Restricted Stock Units | ||
| Accelerant Holdings (Class A) | Mr. Matthew David Sternberg | COO, Risk Exchange | Sale of securities on an exchange or to another person at price $ 14.64 per share. | 23 Jul 2026 | 17,568 | 596,482 | - | 14.6 | 257,206 | Class A Common Shares |
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 17,425 | 166,172 (0%) | 0% | 0 | Class A Common Stock | ||
| Levi Strauss & Co. - Ordinary Shares Cls A | Mr. Harmit J. Singh | EVP & Chief Fin. & Growth Ofc. | 23 Jul 2026 | 17,425 | 0 | - | - | Class B Common Stock | ||
| Intuit | Mr. Anton Hanebrink | EVP, Corp Strategy and Dev | 23 Jul 2026 | 17,209 | 17,209 | - | - | Restricted Stock Units | ||
| Deep Fission Inc | Mr. Jonathon Angell | Director | 23 Jul 2026 | 16,973 | 16,973 | - | - | Restricted Stock Unit | ||
| Lyft Inc - Ordinary Shares Cls A | Mr. Benito Minicucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 15,454 | 15,454 (0%) | 0% | 0 | Class A Common Stock | |
| Incyte | Mr. Lee Heeson | EVP, Head of Incyte Intl | 23 Jul 2026 | 15,423 | 15,423 | - | - | Employee Stock Option (right to buy) | ||
| Yarrow Bioscience Inc | Iain A. Stuart | CHIEF SCIENTIFIC OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.90 per share. | 23 Jul 2026 | 15,405 | 95,944 (0%) | 0% | 0.9 | 13,828 | Common Stock |
| Intuit | Ms. Caryl Lyn Hilliard | EVP, People and Places | 23 Jul 2026 | 15,397 | 15,397 | - | - | Restricted Stock Units | ||
| Brown Forman | Mr. Michael Andrew Masick | EVP/Pres., Americas | 23 Jul 2026 | 15,278 | 15,278 | - | - | Restricted Stock Units | ||
| Intuit | Ms. Lauren D. Hotz | SVP, Chief Accounting Officer | 23 Jul 2026 | 15,048 | 15,048 | - | - | Restricted Stock Units (performance-based vesting) | ||
| Scribe Therapeutics Inc | Dr. Carl L. Gordon, C.F.A.,PhD | Director | 23 Jul 2026 | 14,725 | 14,725 | - | - | Stock Option (Right to Buy) | ||
| Scribe Therapeutics Inc | Dr. Behzad Aghazadeh, PhD | Director, See Remarks | 23 Jul 2026 | 14,725 | 14,725 | - | - | Stock Option (Right to Buy) | ||
| Scribe Therapeutics Inc | Mr. James Dean Watson, M.B.A. | Director | 23 Jul 2026 | 14,725 | 14,725 | - | - | Stock Option (Right to Buy) | ||
| Intuit | Mr. Anton Hanebrink | EVP, Corp Strategy and Dev | 23 Jul 2026 | 14,295 | 14,295 | - | - | Restricted Stock Units (performance-based vesting) | ||
| Incyte | Mr. Lee Heeson | EVP, Head of Incyte Intl | 23 Jul 2026 | 13,498 | 13,498 | - | - | Performance Shares | ||
| Intuit | Ms. Caryl Lyn Hilliard | EVP, People and Places | 23 Jul 2026 | 12,791 | 12,791 | - | - | Restricted Stock Units (performance-based vesting) | ||
| Olema Pharma Inc | Dr. Cyrus L. Harmon, PhD | Director | Sale of securities on an exchange or to another person at price $ 11.71 per share. | 23 Jul 2026 | 12,500 | 702,770 | - | 11.7 | 146,425 | Common Stock |
| Olema Pharma Inc | Dr. Cyrus L. Harmon, PhD | Director | Sale of securities on an exchange or to another person at price $ 11.58 per share. | 23 Jul 2026 | 12,500 | 715,270 | - | 11.6 | 144,738 | Common Stock |
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 23 Jul 2026 | 12,500 | 198,484 | - | - | Class B Common Stock | ||
| PubMatic Inc Ordinary Shares | Mr. Rajeev K. Goel | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | 23 Jul 2026 | 12,500 | 81,671 | - | - | Class A Common Stock | ||
| Weatherford Intl PLC - Ordinary Shares - New | Mr. Neal P. Goldman | Director | Sale of securities on an exchange or to another person at price $ 84.69 per share. | 23 Jul 2026 | 12,439 | 15,748 (0%) | 0% | 84.7 | 1,053,459 | Ordinary Shares |
| Marsh & McLennan | Mr. Lloyd M. Yates | Director | Sale of securities on an exchange or to another person at price $ 175.65 per share. | 23 Jul 2026 | 12,000 | 12,000 (0%) | 0% | 175.7 | 2,107,800 | Common Stock |
| Brown Forman | Mr. Michael E. Carr, Jr | EVP, General Counsel,Secretary | 23 Jul 2026 | 11,458 | 11,458 | - | - | Restricted Stock Units | ||
| Chord Energy Corp - Ordinary Shares - New | Mr. Michael H. Lou | EVP, CSO, and CCO | Sale of securities on an exchange or to another person at price $ 140.42 per share. | 23 Jul 2026 | 10,000 | 72,699 | - | 140.4 | 1,404,200 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 244.45 per share. | 23 Jul 2026 | 9,775 | 7,965 (0%) | 0% | 244.4 | 2,389,491 | Class A Common Stock |
| Brown Forman | Ms. Elizabeth A. Smith | Director | 23 Jul 2026 | 9,523 | 28,063 | - | - | Deferred Stock Units | ||
| Brown Forman | Mr. Mark A. Clouse | Director | 23 Jul 2026 | 9,523 | 27,229 | - | - | Deferred Stock Units | ||
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | 23 Jul 2026 | 9,500 | 284,410 | - | - | Stock Option | ||
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share. | 23 Jul 2026 | 9,500 | 333,943 (0%) | 0% | 135.4 | 1,286,490 | Common Stock |
| Opus Genetics Inc | Dr. George Magrath, PhD | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 23 Jul 2026 | 9,475 | 1,731,869 | - | 2.9 | 27,926 | Common Stock |
| Brown Forman | Mr. Jeremy J Shepherd | EVP, Chief Marketing | 23 Jul 2026 | 9,231 | 9,231 | - | - | Restricted Stock Units | ||
| Brown Forman | Mr. Timothy M. Nall | EVP, Chief Supp/Tech | 23 Jul 2026 | 9,167 | 9,167 | - | - | Restricted Stock Units | ||
| Brown Forman | Ms. Diane F. Nguyen | EVP, Chief Ppl & Comm | 23 Jul 2026 | 9,167 | 9,167 | - | - | Restricted Stock Units | ||
| Symbotic Inc (Class A) | Mr. Brian Daniel Alexander | SVP, Commercial | Sale of securities on an exchange or to another person at price $ 40.30 per share. | 23 Jul 2026 | 9,130 | 55,611 | - | 40.3 | 367,954 | Class A Common Stock |
| Incyte | Mr. Michael James Morrissey | EVP, Head of Tech. Operations | 23 Jul 2026 | 8,999 | 8,999 | - | - | Performance Shares | ||
| Brown Forman | Ms. Christina M. Graven | EVP, Chief Strategy | 23 Jul 2026 | 8,912 | 8,912 | - | - | Restricted Stock Units | ||
| Alaunos Therapeutics Inc | Mr. Jaime W. Vieser | Director | Grant, award, or other acquisition of securities at price $ 1.92 per share. | 23 Jul 2026 | 8,789 | 47,642 (0%) | 0% | 1.9 | 16,875 | Common Stock |
| Alaunos Therapeutics Inc | Mr. Robert W. Postma | Director | Grant, award, or other acquisition of securities at price $ 1.92 per share. | 23 Jul 2026 | 8,463 | 58,609 (0%) | 0% | 1.9 | 16,249 | Common Stock |
| 3M | Mr. John Patrick Banovetz | Executive Vice President | 23 Jul 2026 | 7,880 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | ||
| 3M | Mr. John Patrick Banovetz | Executive Vice President | Sale of securities on an exchange or to another person at price $ 170.44 per share. | 23 Jul 2026 | 7,880 | 50,056 (0%) | 0% | 170.4 | 1,343,067 | Common Stock |
| 3M | Mr. John Patrick Banovetz | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 154.69 per share. | 23 Jul 2026 | 7,880 | 57,936 (0%) | 0% | 154.7 | 1,218,957 | Common Stock |
| Opus Genetics Inc | Mr. Robert Gagnon, M.B.A. | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.95 per share. | 23 Jul 2026 | 7,783 | 584,375 | - | 2.9 | 22,942 | Common Stock |
| Brown Forman | Mr. Yiannis Pafilis | EVP, Pres., EU, Africa, Asia | 23 Jul 2026 | 7,727 | 7,727 | - | - | Restricted Stock Units | ||
| Opus Genetics Inc | Dr. Benjamin R. Yerxa,PhD | Director, President | Sale of securities on an exchange or to another person at price $ 2.97 per share. | 23 Jul 2026 | 7,429 | 704,106 | - | 3.0 | 22,064 | Common Stock |
| Charles Schwab | Mr. Peter J. Morgan, III | General Counsel | Sale of securities on an exchange or to another person at price $ 102.03 per share. | 23 Jul 2026 | 6,952 | 0 (0%) | 0% | 102.0 | 709,341 | Common Stock |
| Immunovant Inc | Mr. Tiago M. Girao | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.69 per share. | 23 Jul 2026 | 6,798 | 240,798 (0%) | 0% | 38.7 | 263,015 | Common Stock |
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 243.70 per share. | 23 Jul 2026 | 6,681 | 650,269 (0%) | 0% | 243.7 | 1,628,146 | Class A Common Stock |
| Brown Forman | Mr. Michael A. Todman | Director | 23 Jul 2026 | 6,476 | 42,555 | - | - | Deferred Stock Units | ||
| Brown Forman | Mr. Michael J. Roney | Director | 23 Jul 2026 | 6,476 | 53,187 | - | - | Deferred Stock Units | ||
| Brown Forman | Mr. Campbell P. Brown | Director | 23 Jul 2026 | 6,476 | 39,422 | - | - | Deferred Stock Units | ||
| Brown Forman | Ms. Jan E. Singer | Director | 23 Jul 2026 | 6,476 | 20,920 | - | - | Deferred Stock Units | ||
| Brown Forman | Ms. Tracy L. Skeans | Director | 23 Jul 2026 | 6,476 | 37,952 | - | - | Deferred Stock Units | ||
| Brown Forman | Mr. Marshall B. Farrer | Director | 23 Jul 2026 | 6,476 | 11,665 | - | - | Deferred Stock Units | ||
| Brown Forman | Ms. Elizabeth M. Brown | Director | 23 Jul 2026 | 6,476 | 19,768 | - | - | Deferred Stock Units | ||
| Incyte | Mr. Michael James Morrissey | EVP, Head of Tech. Operations | 23 Jul 2026 | 6,426 | 6,426 | - | - | Employee Stock Option (right to buy) | ||
| Symbotic Inc (Class A) | Mr. William M. Boyd, III | Chief Strategy Officer | 23 Jul 2026 | 6,285 | 37,710 | - | - | Restricted Stock Units | ||
| Symbotic Inc (Class A) | Mr. William M. Boyd, III | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 6,285 | 66,306 | - | - | Class A Common Stock | |
| Insmed Inc | Mr. William H. Lewis, J.D.,M.B.A. | Director, Chair and CEO | 23 Jul 2026 | 6,260 | 0 | - | - | Stock Option (right to buy) | ||
| Insmed Inc | Mr. William H. Lewis, J.D.,M.B.A. | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.46 per share. | 23 Jul 2026 | 6,260 | 265,318 (0%) | 0% | 30.5 | 190,680 | Common Stock |
| Dana Inc | Mr. James D. Kellett | VP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 6,186 | 12,360 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Dana Inc | Mr. James D. Kellett | VP & Chief Accounting Officer | 23 Jul 2026 | 6,186 | 12,006 | - | - | Restricted Stock Units | ||
| Provident Financial Holdings | Mr. Michael S. Van Stockum | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 6,000 | 10,323 (0%) | 0% | 0 | Common Stock, PAR Value $0.01 | |
| Weatherford Intl PLC - Ordinary Shares - New | Mr. Benjamin C. Duster,IV | Director | Sale of securities on an exchange or to another person at price $ 86.09 per share. | 23 Jul 2026 | 6,000 | 11,187 (0%) | 0% | 86.1 | 516,540 | Ordinary Shares |
| Eos Energy Enterprises Inc (Class A) | Mr. Joseph Nigro | Director | 23 Jul 2026 | 5,942 | 5,942 | - | - | Restricted Stock Units | ||
| Eos Energy Enterprises Inc (Class A) | Mr. Alexander Dimitrief | Director | 23 Jul 2026 | 5,942 | 5,942 | - | - | Restricted Stock Units | ||
| Insmed Inc | Mr. William H. Lewis, J.D.,M.B.A. | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 106.43 per share. | 23 Jul 2026 | 5,872 | 259,058 (0%) | 0% | 106.4 | 624,957 | Common Stock |
| AAR Corp | Mr. Dylan Wolin | Senior VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 5,793 | 17,235 (0%) | 0% | 0 | Common Stock | |
| Symbotic Inc (Class A) | Mr. William M. Boyd, III | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 40.79 per share. | 23 Jul 2026 | 5,700 | 60,606 | - | 40.8 | 232,499 | Class A Common Stock |
| Hilltop Holdings Inc | Mr. Dana Bober | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 5,244 | 5,244 (0%) | 0% | 0 | Common Stock | |
| Hilltop Holdings Inc | Mr. Stephen Haworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 5,244 | 5,244 (0%) | 0% | 0 | Common Stock | |
| AAR Corp | Ms. Jessica A. Garascia | Senior VP, GC, CAO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 5,191 | 43,015 (0%) | 0% | 0 | Common Stock | |
| Peoples Bancorp Of North Carolina Inc | Mr. Robert C. Abernethy, Sr | Director | Sale of securities on an exchange or to another person at price $ 42.14 per share. | 23 Jul 2026 | 5,000 | 113,363 (1%) | 0% | 42.1 | 210,700 | Common Stock |
| First United Corp | Mr. Keith R. Sanders | EVP & Chief Wealth Officer | Sale of securities on an exchange or to another person at price $ 43.68 per share. | 23 Jul 2026 | 5,000 | 10,341 (0%) | 0% | 43.7 | 218,398 | Common Stock |
| Insmed Inc | Mr. William H. Lewis, J.D.,M.B.A. | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 105.62 per share. | 23 Jul 2026 | 4,828 | 264,930 (0%) | 0% | 105.6 | 509,933 | Common Stock |
| Loop Ind Inc | Mr. Jeffrey R. Geygan | Director | Other type of transaction at price $ 0.00 per share. | 23 Jul 2026 | 4,760 | 3,231,969 (8%) | 0% | 0 | Common stock, par value $0.0001 per share | |
| BitMine Immersion Technologies | Mr. Jason A. Edgeworth | Director | 23 Jul 2026 | 4,749 | 9,498 | - | - | Restricted Stock Unit | ||
| BitMine Immersion Technologies | Mr. Jason A. Edgeworth | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 4,749 | 48,137 | - | 0 | Common Stock | |
| BitMine Immersion Technologies | Ms. Olivia Howe | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 4,749 | 48,137 | - | 0 | Common Stock | |
| BitMine Immersion Technologies | Ms. Olivia Howe | Director | 23 Jul 2026 | 4,749 | 9,498 | - | - | Restricted Stock Unit | ||
| BitMine Immersion Technologies | Mr. Robert Sechan | Director | 23 Jul 2026 | 4,749 | 9,498 | - | - | Restricted Stock Unit | ||
| BitMine Immersion Technologies | Mr. Robert Sechan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 4,749 | 48,137 | - | 0 | Common Stock | |
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 246.56 per share. | 23 Jul 2026 | 4,704 | 616,135 (0%) | 0% | 246.6 | 1,159,828 | Class A Common Stock |
| Opus Genetics Inc | Mr. Joseph K. Schachle | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.94 per share. | 23 Jul 2026 | 4,644 | 291,440 | - | 2.9 | 13,653 | Common Stock |
| Alaunos Therapeutics Inc | Mr. Holger Weis | CEO | Grant, award, or other acquisition of securities at price $ 1.92 per share. | 23 Jul 2026 | 4,568 | 21,120 (0%) | 0% | 1.9 | 8,771 | Common Stock |
| Insmed Inc | Mr. William H. Lewis, J.D.,M.B.A. | Director, Chair and CEO | 23 Jul 2026 | 4,440 | 0 | - | - | Stock Option (right to buy) | ||
| Insmed Inc | Mr. William H. Lewis, J.D.,M.B.A. | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.16 per share. | 23 Jul 2026 | 4,440 | 269,758 (0%) | 0% | 17.2 | 76,190 | Common Stock |
| BitMine Immersion Technologies | Ms. Lori L. Love | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 4,374 | 45,531 | - | 0 | Common Stock | |
| BitMine Immersion Technologies | Ms. Lori L. Love | Director | 23 Jul 2026 | 4,374 | 8,748 | - | - | Restricted Stock Unit | ||
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 245.56 per share. | 23 Jul 2026 | 4,196 | 620,839 (0%) | 0% | 245.6 | 1,030,349 | Class A Common Stock |
| BitMine Immersion Technologies | Mr. Michael Maloney | Director | 23 Jul 2026 | 3,999 | 7,998 | - | - | Restricted Stock Unit | ||
| BitMine Immersion Technologies | Mr. Michael Maloney | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,999 | 234,580 | - | 0 | Common Stock | |
| Truist Financial | Mr. K. David Boyer, Jr | Director | Sale of securities on an exchange or to another person at price $ 50.70 per share. | 23 Jul 2026 | 3,986 | 10,270 (0%) | 0% | 50.7 | 202,090 | Common Stock |
| Lazard Ltd (Class A) | Ms. Kathy Elsesser | Director | 23 Jul 2026 | 3,982 | 3,982 | - | - | Deferred Stock Units | ||
| Accelerant Holdings (Class A) | Mr. Matthew David Sternberg | COO, Risk Exchange | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.77 per share. | 23 Jul 2026 | 3,910 | 614,050 | - | 13.8 | 53,841 | Class A Common Shares |
| AAR Corp | Mr. Dylan Wolin | Senior VP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 3,862 | 11,442 (0%) | 0% | 0 | Common Stock | |
| Equity Bancshares Inc (Class A) | Mr. Jerry P. Maland | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Jul 2026 | 3,800 | 109,228 (0%) | 0% | 0 | Class A Common Stock | |
| Weatherford Intl PLC - Ordinary Shares - New | Mr. Neal P. Goldman | Director | Sale of securities on an exchange or to another person at price $ 85.36 per share. | 23 Jul 2026 | 3,561 | 12,187 (0%) | 0% | 85.4 | 303,967 | Ordinary Shares |
| Symbotic Inc (Class A) | Mr. William M. Boyd, III | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 41.46 per share. | 23 Jul 2026 | 3,494 | 57,112 | - | 41.5 | 144,862 | Class A Common Stock |
| AAR Corp | Ms. Jessica A. Garascia | Senior VP, GC, CAO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 3,460 | 37,824 (0%) | 0% | 0 | Common Stock | |
| Symbotic Inc (Class A) | Ms. Maria G. Freve | See Remarks | 23 Jul 2026 | 3,457 | 20,741 | - | - | Restricted Stock Units | ||
| Symbotic Inc (Class A) | Ms. Maria G. Freve | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,457 | 5,340 | - | - | Class A Common Stock | |
| Sono-Tek Corp | Mr. Stephen J. Bagley, C.P.A. | CFO | Sale of securities on an exchange or to another person at price $ 5.43 per share. | 23 Jul 2026 | 3,454 | 30,800 | - | 5.4 | 18,759 | Common Stock |
| Brown Forman | Ms. Crystal L. Peterson | EVP, Chief Incl/Global Comm | 23 Jul 2026 | 3,285 | 3,285 | - | - | Restricted Stock Units | ||
| BOK Fin Corp | Mr. Stacy C. Kymes | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 23 Jul 2026 | 3,215 | 119,957 (0%) | 0% | 0 | Common Stock | |
| CrossAmerica Partners LP - Unit | Mr. John B. Reilly, III | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,154 | 36,621 (0%) | 0% | - | Common Units | |
| CrossAmerica Partners LP - Unit | Mr. Joseph V. Topper, Jr | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,154 | 96,558 (0%) | 0% | - | Common Units | |
| CrossAmerica Partners LP - Unit | Mr. Justin A. Gannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,154 | 39,682 (0%) | 0% | - | Common Units | |
| CrossAmerica Partners LP - Unit | Mr. Mickey Kim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,154 | 33,998 (0%) | 0% | - | Common Units | |
| CrossAmerica Partners LP - Unit | Mr. Kenneth G. Valosky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,154 | 26,958 (0%) | 0% | - | Common Units | |
| CrossAmerica Partners LP - Unit | Mr. Thomas E. Kelso | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 3,154 | 12,298 (0%) | 0% | - | Common Units | |
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 247.65 per share. | 23 Jul 2026 | 3,082 | 613,053 (0%) | 0% | 247.6 | 763,256 | Class A Common Stock |
| Farmers & Merchants Bancorp Inc | Mr. Andrew J. Briggs | Director | Sale of securities on an exchange or to another person at price $ 29.95 per share. | 23 Jul 2026 | 3,000 | 102,550 (0%) | 0% | 30.0 | 89,850 | Common Stock |
| Farmers & Merchants Bancorp Inc | Mr. Andrew J. Briggs | Director | Sale of securities on an exchange or to another person at price $ 30.44 per share. | 23 Jul 2026 | 3,000 | 99,550 (0%) | 0% | 30.4 | 91,320 | Common Stock |
| Enerpac Tool Grp Corp (Class A) | Mr. E. James Ferland | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.95 per share. | 23 Jul 2026 | 2,930 | 102,611 (0%) | 0% | 27.0 | 78,964 | Class A Common Stock |
| Enerpac Tool Grp Corp (Class A) | Mr. E. James Ferland | Director | 23 Jul 2026 | 2,930 | 0 | - | - | Director Stock Option (Right to Buy) | ||
| Enerpac Tool Grp Corp (Class A) | Mr. E. James Ferland | Director | Sale of securities on an exchange or to another person at price $ 34.35 per share. | 23 Jul 2026 | 2,930 | 99,681 (0%) | 0% | 34.4 | 100,646 | Class A Common Stock |
| Enerpac Tool Grp Corp (Class A) | Mr. Danny L. Cunningham | Director | 23 Jul 2026 | 2,930 | 0 | - | - | Director Stock Option (Right to Buy) | ||
| Enerpac Tool Grp Corp (Class A) | Mr. Danny L. Cunningham | Director | Sale of securities on an exchange or to another person at price $ 34.35 per share. | 23 Jul 2026 | 2,930 | 24,030 (0%) | 0% | 34.4 | 100,646 | Class A Common Stock |
| Enerpac Tool Grp Corp (Class A) | Mr. Danny L. Cunningham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.95 per share. | 23 Jul 2026 | 2,930 | 26,960 (0%) | 0% | 27.0 | 78,964 | Class A Common Stock |
| Symbotic Inc (Class A) | Mr. William M. Boyd, III | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 2,909 | 60,021 | - | - | Class A Common Stock | |
| Symbotic Inc (Class A) | Mr. William M. Boyd, III | Chief Strategy Officer | 23 Jul 2026 | 2,909 | 5,819 | - | - | Restricted Stock Units | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 243.42 per share. | 23 Jul 2026 | 2,900 | 17,740 (0%) | 0% | 243.4 | 705,913 | Class A Common Stock |
| Immunovant Inc | Dr. Jay S. Stout, PhD | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 38.69 per share. | 23 Jul 2026 | 2,857 | 205,341 (0%) | 0% | 38.7 | 110,537 | Common Stock |
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 242.65 per share. | 23 Jul 2026 | 2,851 | 656,950 (1%) | 0% | 242.7 | 691,807 | Class A Common Stock |
| Viant Tech Inc (Class A) | Lawrence J. Madden | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.69 per share. | 23 Jul 2026 | 2,814 | 425,822 | - | 10.7 | 30,070 | Class A Common Stock |
| Angel Studios Inc Ordinary | Dr. Robert C. Gay, PhD | Director | 23 Jul 2026 | 2,648 | 2,649 | - | - | Class A Common Stock Restricted Stock Units | ||
| Angel Studios Inc Ordinary | Dr. Robert C. Gay, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 2,648 | 7,944 | - | - | Class A Common Stock, par value $0.0001 per share | |
| Angel Studios Inc Ordinary | Mr. Steven I. Sarowitz | Director | 23 Jul 2026 | 2,648 | 2,649 | - | - | Class A Common Stock Restricted Stock Units | ||
| Angel Studios Inc Ordinary | Mr. Steven I. Sarowitz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 2,648 | 329,488 | - | - | Class A Common Stock, par value $0.0001 per share | |
| Angel Studios Inc Ordinary | Dr. Katie Liljenquist, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 2,648 | 58,297 | - | - | Class A Common Stock, par value $0.0001 per share | |
| Angel Studios Inc Ordinary | Dr. Katie Liljenquist, PhD | Director | 23 Jul 2026 | 2,648 | 2,649 | - | - | Class A Common Stock Restricted Stock Units | ||
| Angel Studios Inc Ordinary | Mr. Benton Deloss Crane | Director | 23 Jul 2026 | 2,648 | 2,649 | - | - | Class A Common Stock Restricted Stock Units | ||
| Angel Studios Inc Ordinary | Mr. Benton Deloss Crane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 2,648 | 207,944 | - | - | Class A Common Stock, par value $0.0001 per share | |
| Greenwich LifeSciences Inc | Mr. Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.14 per share. | 23 Jul 2026 | 2,500 | 5,606,602 | - | 13.1 | 32,850 | Common Stock |
| Stifel Fin Corp | Ms. Maryam S. Brown | Director | Sale of securities on an exchange or to another person at price $ 79.25 per share. | 23 Jul 2026 | 2,500 | 7,929 (0%) | 0% | 79.3 | 198,125 | Common Stock |
| Brown Forman | Ms. Angela S. Enyard | SVP, Chief Accounting Officer | 23 Jul 2026 | 2,450 | 2,450 | - | - | Restricted Stock Units | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 246.54 per share. | 23 Jul 2026 | 2,281 | 3,550 (0%) | 0% | 246.5 | 562,349 | Class A Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 529.86 per share. | 23 Jul 2026 | 2,279 | 325,844 (0%) | 0% | 529.9 | 1,207,540 | Common Stock |
| Symbotic Inc (Class A) | Ms. Maria G. Freve | See Remarks | Sale of securities on an exchange or to another person at price $ 40.28 per share. | 23 Jul 2026 | 2,244 | 3,096 | - | 40.3 | 90,394 | Class A Common Stock |
| Twist Bioscience Corp | Dr. Patrick Finn, PhD | President and COO | Sale of securities on an exchange or to another person at price $ 93.89 per share. | 23 Jul 2026 | 2,238 | 272,566 (0%) | 0% | 93.9 | 210,133 | Common Stock |
| Stifel Fin Corp | Ms. Maryam S. Brown | Director | Sale of securities on an exchange or to another person at price $ 79.14 per share. | 23 Jul 2026 | 2,200 | 5,729 (0%) | 0% | 79.1 | 174,108 | Common Stock |
| UDR | Mr. David D. Bragg | SVP - Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.48 per share. | 23 Jul 2026 | 2,134 | 27,892 (0%) | 0% | 39.5 | 84,250 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 245.46 per share. | 23 Jul 2026 | 2,134 | 5,831 (0%) | 0% | 245.5 | 523,811 | Class A Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 529.08 per share. | 23 Jul 2026 | 2,133 | 328,123 (0%) | 0% | 529.1 | 1,128,525 | Common Stock |
| AAR Corp | Mr. Eric S. Pachapa | VP-CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 2,086 | 29,166 (0%) | 0% | 0 | Common Stock | |
| HCM II Acq Corp (Class A) | Ms. Kathryn Ann McCarthy | Director | 23 Jul 2026 | 2,049 | 2,049 | - | - | Restricted Stock Units | ||
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 527.77 per share. | 23 Jul 2026 | 1,989 | 330,256 (0%) | 0% | 527.8 | 1,049,730 | Common Stock |
| Dana Inc | Mr. James D. Kellett | VP & Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.04 per share. | 23 Jul 2026 | 1,799 | 10,662 (0%) | 0% | 28.0 | 50,444 | Common Stock, par value $0.01 |
| Smart Sand Inc | Mr. Christopher Green | Vice President of Accounting | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.81 per share. | 23 Jul 2026 | 1,738 | 48,167 (0%) | 0% | 4.8 | 8,360 | Common Stock, par value $0.001 per share |
| Allegion | Mr. Michael J. Wagnes | SVP and CFO | Sale of securities on an exchange or to another person at price $ 150.98 per share. | 23 Jul 2026 | 1,716 | 31,299 (0%) | 0% | 151.0 | 259,082 | Ordinary Shares |
| Allegion | Mr. Michael J. Wagnes | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.84 per share. | 23 Jul 2026 | 1,716 | 33,015 (0%) | 0% | 71.8 | 123,269 | Ordinary Shares |
| Allegion | Mr. Michael J. Wagnes | SVP and CFO | 23 Jul 2026 | 1,716 | 0 | - | - | Stock Option (Right to Buy) | ||
| Usana Health Sciences Inc | Dr. Timothy E. Wood, PhD | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Dr. Timothy E. Wood, PhD | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 12,245 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mr. Gilbert A. Fuller | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 1,632 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mr. Gilbert A. Fuller | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Mr. Frederic J. Winssinger | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 9,733 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mr. Frederic J. Winssinger | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Mr. J. Scott Nixon, C.P.A. | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Mr. J. Scott Nixon, C.P.A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 11,445 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Ms. Peggie J. Pelosi | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Ms. Peggie J. Pelosi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 6,996 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Mr. John T. Fleming | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| Usana Health Sciences Inc | Mr. John T. Fleming | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 5,862 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Ms. Xia Ding | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,632 | 8,882 (0%) | 0% | - | Common Stock | |
| Usana Health Sciences Inc | Ms. Xia Ding | Director | 23 Jul 2026 | 1,632 | 4,895 | - | - | Restricted Stock Units | ||
| General Electric Co. | Mr. Riccardo Procacci | Senior Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.33 per share. | 23 Jul 2026 | 1,517 | 33,548 (0%) | 0% | 146.3 | 221,983 | Common Stock |
| General Electric Co. | Mr. Riccardo Procacci | Senior Vice President | 23 Jul 2026 | 1,517 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Allegion | Mr. Michael J. Wagnes | SVP and CFO | Sale of securities on an exchange or to another person at price $ 150.98 per share. | 23 Jul 2026 | 1,468 | 31,299 (0%) | 0% | 151.0 | 221,639 | Ordinary Shares |
| Allegion | Mr. Michael J. Wagnes | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.93 per share. | 23 Jul 2026 | 1,468 | 32,767 (0%) | 0% | 86.9 | 127,613 | Ordinary Shares |
| Allegion | Mr. Michael J. Wagnes | SVP and CFO | 23 Jul 2026 | 1,468 | 0 | - | - | Stock Option (Right to Buy) | ||
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 247.66 per share. | 23 Jul 2026 | 1,410 | 2,140 (0%) | 0% | 247.7 | 349,201 | Class A Common Stock |
| AAR Corp | Mr. Eric S. Pachapa | VP-CAO & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 1,390 | 27,080 (0%) | 0% | 0 | Common Stock | |
| Penguin Soln Inc | Mr. Joseph Clark | SVP and Pres, Optimized LED | Sale of securities on an exchange or to another person at price $ 57.47 per share. | 23 Jul 2026 | 1,327 | 63,056 (0%) | 0% | 57.5 | 76,263 | Common Stock |
| Ranger Energy Services Inc (Class A) | Mr. J. Matt Hooker | Exec VP, Well Services | Sale of securities on an exchange or to another person at price $ 16.50 per share. | 23 Jul 2026 | 1,291 | 99,148 (1%) | 0% | 16.5 | 21,302 | Class A Common Stock |
| JFrog Ltd | Mr. Barry Zwarenstein | Director | Sale of securities on an exchange or to another person at price $ 80.10 per share. | 23 Jul 2026 | 1,250 | 31,687 | - | 80.1 | 100,125 | Ordinary Shares |
| Vicor Corp | Ms. Zmira Shternfeld-Lavie | Director | 23 Jul 2026 | 1,216 | 3,648 | - | - | Non Qualified Stock Option | ||
| Vicor Corp | Ms. Zmira Shternfeld-Lavie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.89 per share. | 23 Jul 2026 | 1,216 | 1,216 (0%) | 0% | 32.9 | 39,994 | Common Stock |
| Vicor Corp | Ms. Zmira Shternfeld-Lavie | Director | Sale of securities on an exchange or to another person at price $ 224.72 per share. | 23 Jul 2026 | 1,216 | 0 (0%) | 0% | 224.7 | 273,260 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 530.84 per share. | 23 Jul 2026 | 1,201 | 324,643 (0%) | 0% | 530.8 | 637,540 | Common Stock |
| Peoples Bancorp Of North Carolina Inc | Mr. Robert C. Abernethy, Sr | Director | Sale of securities on an exchange or to another person at price $ 41.75 per share. | 23 Jul 2026 | 1,200 | 59,716 (1%) | 0% | 41.8 | 50,100 | Common Stock |
| Hilltop Holdings Inc | Mr. Carl B. Webb | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 132,078 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. J. Taylor Crandall | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 2,137 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. Rhodes R. Bobbitt | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 88,196 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. Thomas C. Nichols | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 16,317 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. Lee Lewis | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 54,919 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. W. Robert Nichols, III | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 2,195 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. Kenneth D. Russell | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 2,137 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. Robert C. Taylor, Jr | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 46,470 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Hilltop Holdings Inc | Mr. Jonathan S. Sobel | Director, Hilltop Securities Chairman | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 1,180 | 129,795 (0%) | 0% | 38.1 | 45,005 | Common Stock |
| Progressive | Mr. Steven A. Broz | Chief Information Officer | Sale of securities on an exchange or to another person at price $ 205.17 per share. | 23 Jul 2026 | 1,156 | 26,354 (0%) | 0% | 205.2 | 237,177 | Common |
| Symbotic Inc (Class A) | Ms. Maria G. Freve | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 1,144 | 1,883 | - | - | Class A Common Stock | |
| Symbotic Inc (Class A) | Ms. Maria G. Freve | See Remarks | 23 Jul 2026 | 1,144 | 3,432 | - | - | Restricted Stock Units | ||
| Greenwich LifeSciences Inc | Mr. Snehal S. Patel | Director, CEO and CFO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 12.88 per share. | 23 Jul 2026 | 1,100 | 5,607,702 | - | 12.9 | 14,168 | Common Stock |
| McCormick & Company | Mr. Michael A. Conway | Director | Purchase of securities on an exchange or from another person at price $ 50.21 per share. | 23 Jul 2026 | 1,100 | 1,100 (0%) | 0% | 50.2 | 55,227 | Common Stock - Non Voting |
| General Electric Co. | Mr. Riccardo Procacci | Senior Vice President | Sale of securities on an exchange or to another person at price $ 347.93 per share. | 23 Jul 2026 | 1,026 | 32,522 (0%) | 0% | 347.9 | 356,976 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 242.38 per share. | 23 Jul 2026 | 1,000 | 20,640 (0%) | 0% | 242.4 | 242,383 | Class A Common Stock |
| Metropolitan Bank Holding Corp | Mr. Daniel F. Dougherty | EVP & Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 89.98 per share. | 23 Jul 2026 | 1,000 | 33,197 (0%) | 0% | 90.0 | 89,980 | Common Stock |
| Avis Budget Grp Inc | Mr. Daniel Cunha | EVP and CFO | 23 Jul 2026 | 969 | 1,940 | - | - | Restricted Stock Units | ||
| Avis Budget Grp Inc | Mr. Daniel Cunha | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 969 | 969 (0%) | 0% | 0 | Common Stock | |
| Usana Health Sciences Inc | Ms. Peggie J. Pelosi | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.92 per share. | 23 Jul 2026 | 935 | 6,061 (0%) | 0% | 20.9 | 19,560 | Common Stock |
| 3M | Ms. Theresa E. Reinseth | Sr Vice President & CAO | Sale of securities on an exchange or to another person at price $ 169.42 per share. | 23 Jul 2026 | 924 | 2,615 (0%) | 0% | 169.4 | 156,544 | Common Stock |
| Micron Tech | Mr. Scott R. Allen | CVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 1000.00 per share. | 23 Jul 2026 | 879 | 34,958 (0%) | 0% | 1000 | 879,000 | Common Stock |
| Avery Dennison | Mr. David E. Flitman | Director | 23 Jul 2026 | 765 | 0 | - | - | New Director RSUs | ||
| Avery Dennison | Mr. David E. Flitman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 156.11 per share. | 23 Jul 2026 | 765 | 765 (0%) | 0% | 156.1 | 119,424 | Common Stock |
| Allegion | Mr. Nickolas A. Musial | VP, Controller & CAO | 23 Jul 2026 | 687 | 0 | - | - | Stock Option (Right to Buy) | ||
| Allegion | Mr. Nickolas A. Musial | VP, Controller & CAO | Sale of securities on an exchange or to another person at price $ 155.00 per share. | 23 Jul 2026 | 687 | 6,798 (0%) | 0% | 155 | 106,485 | Ordinary Shares |
| Allegion | Mr. Nickolas A. Musial | VP, Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.84 per share. | 23 Jul 2026 | 687 | 7,485 (0%) | 0% | 71.8 | 49,351 | Ordinary Shares |
| Usana Health Sciences Inc | Ms. Xia Ding | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.92 per share. | 23 Jul 2026 | 604 | 8,278 (0%) | 0% | 20.9 | 12,636 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 526.88 per share. | 23 Jul 2026 | 552 | 332,245 (0%) | 0% | 526.9 | 290,835 | Common Stock |
| Datadog Inc (Class A) | Mr. Amit Agarwal | Director | Sale of securities on an exchange or to another person at price $ 248.37 per share. | 23 Jul 2026 | 500 | 1,640 (0%) | 0% | 248.4 | 124,186 | Class A Common Stock |
| General Electric Co. | Mr. Riccardo Procacci | Senior Vice President | Sale of securities on an exchange or to another person at price $ 347.90 per share. | 23 Jul 2026 | 491 | 32,031 (0%) | 0% | 347.9 | 170,819 | Common Stock |
| John Wiley & Sons Inc (Class A) | Mr. Raymond W. Mcdaniel, Jr | Director | 23 Jul 2026 | 462 | 63,407 | - | - | Phantom Stock Units | ||
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.60 per share. | 23 Jul 2026 | 448 | 7,697 (0%) | 0% | 47.6 | 21,325 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | 23 Jul 2026 | 448 | 0 | - | - | Stock Option (Right to Buy) | ||
| Pacific Gas & Electric | Mr. Alejandro T. Vallejo | EVP, Chief People Officer | 23 Jul 2026 | 422 | 34,509 | - | - | Phantom Stock | ||
| National Grid PLC (ADR) | Ms. Paula Rosput Reynolds | Non-Executive Director,Chairman | 23 Jul 2026 | 410 | 28,803 (0%) | 0% | 16.1 | 6,605 | Ords | |
| Usana Health Sciences Inc | Dr. Timothy E. Wood, PhD | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.92 per share. | 23 Jul 2026 | 408 | 11,837 (0%) | 0% | 20.9 | 8,535 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 525.83 per share. | 23 Jul 2026 | 387 | 332,797 (0%) | 0% | 525.8 | 203,497 | Common Stock |
| Bio-Techne | Mr. Shane Bohnen | SVP - General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.77 per share. | 23 Jul 2026 | 344 | 7,353 (0%) | 0% | 71.8 | 24,689 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 523.72 per share. | 23 Jul 2026 | 339 | 333,355 (0%) | 0% | 523.7 | 177,540 | Common Stock |
| John Wiley & Sons Inc (Class A) | Ms. Mari Jean Baker | Director | 23 Jul 2026 | 311 | 42,684 | - | - | Phantom Stock Units | ||
| Datadog Inc (Class A) | Mr. Olivier Pomel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 248.33 per share. | 23 Jul 2026 | 306 | 612,747 (0%) | 0% | 248.3 | 75,988 | Class A Common Stock |
| Avis Budget Grp Inc | Mr. Daniel Cunha | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 159.04 per share. | 23 Jul 2026 | 304 | 665 (0%) | 0% | 159.0 | 48,348 | Common Stock |
| Hilltop Holdings Inc | Mr. Dana Bober | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 291 | 5,535 (0%) | 0% | 38.1 | 11,099 | Common Stock |
| Hilltop Holdings Inc | Mr. Stephen Haworth | Director | Grant, award, or other acquisition of securities at price $ 38.14 per share. | 23 Jul 2026 | 291 | 5,535 (0%) | 0% | 38.1 | 11,099 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 522.87 per share. | 23 Jul 2026 | 249 | 333,694 (0%) | 0% | 522.9 | 130,195 | Common Stock |
| John Wiley & Sons Inc (Class A) | Mr. David C. Dobson | Director | 23 Jul 2026 | 230 | 31,619 | - | - | Phantom Stock Units | ||
| Lincoln Electric Holdings Inc | Mr. Kevin J. Whaley | EVP, Pres, Global Automation | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.38 per share. | 23 Jul 2026 | 216 | 2,640 (0%) | 0% | 250.4 | 54,082 | Common Shares |
| Valmont Ind Inc | Mr. John Schwietz | Executive VP and CFO | Purchase of securities on an exchange or from another person at price $ 486.14 per share. | 23 Jul 2026 | 208 | 2,992 (0%) | 0% | 486.1 | 101,118 | Common Stock |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 531.84 per share. | 23 Jul 2026 | 200 | 324,443 (0%) | 0% | 531.8 | 106,367 | Common Stock |
| New York Times Co. (Class A) | Mr. Brian P. Mcandrews | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 176 | 60,174 (0%) | 0% | 0 | Class A Common Stock | |
| New York Times Co. (Class A) | Ms. Rebecca Van Dyck | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 176 | 57,014 (0%) | 0% | 0 | Class A Common Stock | |
| United Therapeutics Corp | Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD | Director, Chairperson & CEO | Sale of securities on an exchange or to another person at price $ 524.86 per share. | 23 Jul 2026 | 171 | 333,184 (0%) | 0% | 524.9 | 89,751 | Common Stock |
| National Grid PLC (ADR) | Mr. Andrew Agg | Executive Director,Chief Financial Officer | 23 Jul 2026 | 140 | 1,022,027 (0%) | 0% | 12.4 | 1,736 | Ords | |
| John Wiley & Sons Inc (Class A) | Mr. Inder M. Singh | Director | 23 Jul 2026 | 114 | 15,615 | - | - | Phantom Stock Units | ||
| New York Times Co. (Class A) | Ms. Rachel C. Glaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 110 | 35,888 (0%) | 0% | 0 | Class A Common Stock | |
| New York Times Co. (Class A) | Mr. John W. Rogers, Jr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 106 | 54,598 (0%) | 0% | 0 | Class A Common Stock | |
| John Wiley & Sons Inc (Class A) | Dr. Brian O. Hemphill, PhD | Director | 23 Jul 2026 | 105 | 14,395 | - | - | Phantom Stock Units | ||
| Dana Inc | Mr. James D. Kellett | VP & Chief Accounting Officer | 23 Jul 2026 | 101 | 606 | - | - | Dividend Equivalent Rights | ||
| Dana Inc | Mr. James D. Kellett | VP & Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2026 | 101 | 12,461 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| New York Times Co. (Class A) | Mr. Amanpal S. Bhutani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 98 | 32,147 (0%) | 0% | 0 | Class A Common Stock | |
| Ryerson Holding Corp | Mr. Kirk K. Calhoun | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 97 | 4,673 (0%) | 0% | 0 | - | |
| Ryerson Holding Corp | Ms. Karen M. Leggio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 97 | 5,369 (0%) | 0% | 0 | - | |
| Ryerson Holding Corp | Mr. Court D. Carruthers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 97 | 6,173 (0%) | 0% | 0 | - | |
| Ryerson Holding Corp | Ms. Michelle A. Kumbier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 97 | 3,242 (0%) | 0% | 0 | - | |
| Ryerson Holding Corp | Mr. Richard P. Stovsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 97 | 17,799 (0%) | 0% | 0 | - | |
| CRA Intl Inc | Ms. Heather E. Tookes, PhD | Director | Sale of securities on an exchange or to another person at price $ 165.90 per share. | 23 Jul 2026 | 88 | 3,718 (0%) | 0% | 165.9 | 14,599 | Common Stock |
| National Grid PLC (ADR) | Ms. Paula Rosput Reynolds | Non-Executive Director,Chairman | 23 Jul 2026 | 82 | 28,885 (0%) | 0% | 12.0 | 982 | Ords | |
| New York Times Co. (Class A) | Mr. Arthur Golden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 70 | 22,911 (0%) | 0% | 0 | Class A Common Stock | |
| New York Times Co. (Class A) | Ms. Beth A. Brooke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 68 | 22,167 (0%) | 0% | 0 | Class A Common Stock | |
| New York Times Co. (Class A) | Mr. Manuel Bronstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 62 | 20,405 (0%) | 0% | 0 | Class A Common Stock | |
| John Wiley & Sons Inc (Class A) | Dr. Karen N. Madden, PhD | Director | 23 Jul 2026 | 39 | 5,376 | - | - | Phantom Stock Units | ||
| New York Times Co. (Class A) | Ms. Anuradha B. Subramanian | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 36 | 11,935 (0%) | 0% | 0 | Class A Common Stock | |
| John Wiley & Sons Inc (Class A) | Ms. Katya D. Andresen | Director | 23 Jul 2026 | 31 | 4,211 | - | - | Phantom Stock Units | ||
| New York Times Co. (Class A) | Ms. Margot Golden Tishler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jul 2026 | 31 | 10,075 (0%) | 0% | 0 | Class A Common Stock | |
| Valvoline Inc | Ms. Lori Ann Flees | Director, President & CEO | 23 Jul 2026 | 25 | 15,628 | - | - | Deferred Stock Units | ||
| Pro-Dex Inc (co) | Ms. Angelita R. Domingo | Director | Grant, award, or other acquisition of securities at price $ 33.26 per share. | 23 Jul 2026 | 19 | 18,798 (0%) | 0% | 33.3 | 632 | Common Stock |
| BOK Fin Corp | Mr. Stacy C. Kymes | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 148.88 per share. | 23 Jul 2026 | 8 | 123,172 (0%) | 0% | 148.9 | 1,191 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.